Rizatriptan in migraineurs with unilateral cranial autonomic symptoms: a double-blind trial

The objective and background is to confirm in a double-blind, placebo-controlled study the high triptan response rates we had previously reported in an open study in migraine patients with unilateral cranial autonomic symptoms. In this randomized, double-blind, placebo-controlled study 80 migraineur...

Descripción completa

Detalles Bibliográficos
Autores principales: Barbanti, Piero, Fofi, Luisa, Dall’Armi, Valentina, Aurilia, Cinzia, Egeo, Gabriella, Vanacore, Nicola, Bonassi, Stefano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Milan 2012
Materias:
Clinical Trials
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3381061/
https://www.ncbi.nlm.nih.gov/pubmed/22460943
http://dx.doi.org/10.1007/s10194-012-0440-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3381061/
https://www.ncbi.nlm.nih.gov/pubmed/22460943
http://dx.doi.org/10.1007/s10194-012-0440-y

Ejemplares similares